Lameness case 4
Case Overview
Patient: 6-year-old Thoroughbred mare named Poor Investment
Situation: Called to assess after racing 2 hours ago on soft ground
Concern: Groom suspects injury due to poor performance
History: 15 previous races with 3 wins, previously no injuries
Initial Clinical Examination
Observation: Obvious swelling on the palmar aspect of the right front metacarpus
Findings upon palpation:
Diffuse oedematous swelling over tendons/ligaments
Area warmer than contralateral limb
Signs of discomfort on pressure application
Lameness: Obvious lameness noted during walking, trotting not conducted due to discomfort
Conclusion: Signs indicative of inflammation present
Initial Management
Suspected injury: Tendon or ligament damage
Immediate therapy recommendations:
NSAIDs: Provide analgesia and anti-inflammatory effects
Corticosteroids: Single IV dose for potent anti-inflammatory effect
Bandaging/Splinting: External support to reduce swelling
Stable confinement: Absolute rest to prevent exacerbation
Re-examination: In 1-3 days
Feedback: Highlighting the importance of NSAIDs in treatment
Re-examination Findings (2 days later)
Appearance: Bandage removal shows significant swelling on palmar aspect of the limb
Palpation Results::
Swollen area warmer than contralateral limb
Pain response when pressure is applied
Indication: Significant localized inflammation still present
Dynamic Exam Findings
Walking Assessment: Comfortably walks straight, discomfort turning right
Trotting Assessment: Severe 4/5 lameness observed
Behavior: Head drops when left front hits the ground, indicating pain
Diagnostic Imaging
Initial Imaging Modality: Ultrasound preferred for soft tissue injuries
Ultrasound Examination**
Findings:
Transverse section shows single large oval hypoechoic lesion in superficial digital flexor tendon
Lesion indicates fiber separation (tendinopathy)
Assessing Severity of Injury
Measurement Comparison: Cross-sectional area of injured vs non-injured limb
Left fore: 1.0 cm²; Right fore: 1.4 cm² (40% increase)
Lesion Coverage: 0.35 cm² lesion covering 25% of total tendon area (1.4 cm²)
Management During Inflammatory Phase
Duration: 2-4 weeks of the inflammatory phase
Required Therapies:
NSAIDs (oral or topical)
Cold therapies (ice application)
Bandaging to reduce swelling
Strict box rest required until inflammation subsides
Management During Repair Phase
Exercise Progression Plan:
Month 1: Box rest, no exercise
Months 2-3: Box rest, hand walking
Months 4-5: Small pen rest, ridden walking exercise
Months 6-9: Small pen rest with trotting
Months 9-12: Field turn out with canter exercise
Expected Return to Racing: Approximately 1 year post-injury
Intralesional Therapies for Repair Phase
Indications for Therapy: Lesions with a 'hole' in the tendon/ligament
Biological Therapy Options:
Mesenchymal stem cells (MSCs)
Platelet-rich plasma (PRP)
Bone marrow aspirate concentrate (BMAC)
Objective: Promote improved healing and reduce recurrence
Prognosis
Chance of Recovery: 80% chance of returning to racing
Performance Impact: Initially unlikely to alter performance
Re-injury Risk: 53% chance of re-injury within 3 years
Reference: Equine Vet J 2010 May;42(4):322-6.